These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The biophysics, biochemistry and physiology of CFTR. Moran O Cell Mol Life Sci; 2017 Jan; 74(1):1-2. PubMed ID: 27704173 [No Abstract] [Full Text] [Related]
7. Cystic fibrosis transmembrane conductance regulator is expressed in mucin granules from Calu-3 and primary human airway epithelial cells. LeSimple P; Goepp J; Palmer ML; Fahrenkrug SC; O'Grady SM; Ferraro P; Robert R; Hanrahan JW Am J Respir Cell Mol Biol; 2013 Oct; 49(4):511-6. PubMed ID: 23742042 [TBL] [Abstract][Full Text] [Related]
8. [New therapeutic developments in cystic fibrosis]. Bui S; Macey J; Fayon M; ; Bihouée T; Burgel PR; Colomb V; Corvol H; Durieu I; Hubert D; Marguet C; Mas E; Munck A; Murris-Espin M; Reix P; Sermet-Gaudelus I Arch Pediatr; 2016 Dec; 23(12S):12S47-12S53. PubMed ID: 28231894 [TBL] [Abstract][Full Text] [Related]
10. [CFTR protein and molecular mechanisms of pulmonary involvement in cystic fibrosis]. Chinet T Rev Pneumol Clin; 1995; 51(3):122-9. PubMed ID: 7569573 [TBL] [Abstract][Full Text] [Related]
11. How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease? Pilewski JM; Frizzell RA Curr Opin Pulm Med; 1995 Nov; 1(6):435-43. PubMed ID: 9363079 [TBL] [Abstract][Full Text] [Related]
12. Ten years with CFTR. Frizzell RA Physiol Rev; 1999 Jan; 79(1 Suppl):S1-2. PubMed ID: 9922373 [No Abstract] [Full Text] [Related]
13. Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator. Kunzelmann K; Nitschke R Exp Nephrol; 2000; 8(6):332-42. PubMed ID: 11014930 [TBL] [Abstract][Full Text] [Related]
14. Structure and function of the cystic fibrosis transmembrane conductance regulator. Morales MM; Capella MA; Lopes AG Braz J Med Biol Res; 1999 Aug; 32(8):1021-8. PubMed ID: 10454765 [TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function. Stanton BA Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986 [TBL] [Abstract][Full Text] [Related]
16. Actions of adenosine A1 and A2 receptor antagonists on CFTR antibody-inhibited beta-adrenergic mucin secretion response. Pereira MM; Lloyd Mills C; Dormer RL; McPherson MA Br J Pharmacol; 1998 Oct; 125(4):697-704. PubMed ID: 9831904 [TBL] [Abstract][Full Text] [Related]
17. [From the laboratory to the clinic: CFTR and the therapeutic options for cystic fibrosis]. Mayol J; Alvarez de Arcaya Vicente A; Arbeo Escolar AM; Peña Soria MJ; Alvarez Fernández-Represa J An Med Interna; 2000 Feb; 17(2):92-8. PubMed ID: 10829466 [TBL] [Abstract][Full Text] [Related]
18. CFTR, bicarbonate, and the pathophysiology of cystic fibrosis. Borowitz D Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S24-S30. PubMed ID: 26335950 [TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis serum stimulates mucin secretion but not calcium efflux from rat submandibular acini. McPherson MA; Dodge JA; Goodchild MC Clin Chim Acta; 1983 Dec; 135(2):181-8. PubMed ID: 6197214 [TBL] [Abstract][Full Text] [Related]
20. An antibody against a CFTR-derived synthetic peptide, incorporated into living submandibular cells, inhibits beta-adrenergic stimulation of mucin secretion. Mills CL; Pereira MM; Dormer RL; McPherson MA Biochem Biophys Res Commun; 1992 Nov; 188(3):1146-52. PubMed ID: 1280131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]